BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 22447257)

  • 21. Other causes of PAH (schistosomiasis, porto-pulmonary hypertension and hemolysis-associated pulmonary hypertension).
    Souza R; Fernandes CJ; Jardim CV
    Semin Respir Crit Care Med; 2009 Aug; 30(4):448-57. PubMed ID: 19634084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of portopulmonary hypertension: new perspectives.
    Mancuso L; Scordato F; Pieri M; Valerio E; Mancuso A
    World J Gastroenterol; 2013 Dec; 19(45):8252-7. PubMed ID: 24363516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexisting hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
    Pham DM; Subramanian R; Parekh S
    J Clin Gastroenterol; 2010 Aug; 44(7):e136-40. PubMed ID: 20463591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Portopulmonary hypertension.
    Mukhtar NA; Fix OK
    J Clin Gastroenterol; 2011 Sep; 45(8):703-10. PubMed ID: 21325952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
    Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
    Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Porto-pulmonary hypertension].
    Chabot F; Gomez E; Boyer L; Kheir A; Le Pavec J; Sitbon O; Herve P
    Rev Mal Respir; 2006 Dec; 23(6):629-41. PubMed ID: 17202968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report.
    Stratta C; Lavezzo B; Ballaris MA; Panio A; Crucitti M; Andruetto P; Fanelli V; Grosso Marra W; Ranieri MV; Salizzoni M
    Transplant Proc; 2013 Sep; 45(7):2774-5. PubMed ID: 24034045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Portopulmonary hypertension.
    Lv Y; Han G; Fan D
    Scand J Gastroenterol; 2016 Jul; 51(7):795-806. PubMed ID: 27002212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Approach to the Diagnosis and Management of Portopulmonary Hypertension.
    Fussner LA; Krowka MJ
    Curr Gastroenterol Rep; 2016 Jun; 18(6):29. PubMed ID: 27098816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
    Krowka MJ
    Clin Chest Med; 2005 Dec; 26(4):587-97, vi. PubMed ID: 16263398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The portopulmonary hypertension: an overview from diagnosis to treatment].
    Salzano A; Sirico D; Golia L; Faga V; Flora M; Bossone E; Cittadini A
    Monaldi Arch Chest Dis; 2013 Jun; 80(2):66-8. PubMed ID: 24494409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension.
    Hollatz TJ; Musat A; Westphal S; Decker C; D'Alessandro AM; Keevil J; Zhanhai L; Runo JR
    Liver Transpl; 2012 Jun; 18(6):686-95. PubMed ID: 22315210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception.
    DuBrock HM; Del Valle KT; Krowka MJ
    Liver Transpl; 2022 Jul; 28(7):1224-1230. PubMed ID: 35106916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic options in pulmonary hepatic vascular diseases.
    Horvatits T; Fuhrmann V
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):31-42. PubMed ID: 24308785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pulmonary hypertension in liver diseases].
    Savale L; Sattler C; Sitbon O
    Presse Med; 2014 Sep; 43(9):970-80. PubMed ID: 25148949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Portopulmonary hypertension.
    Barua UK; Hossain AS; Roy GC; Rahman MA; Das M
    Mymensingh Med J; 2013 Jul; 22(3):618-24. PubMed ID: 23982562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension.
    Findlay JY; Harrison BA; Plevak DJ; Krowka MJ
    Liver Transpl Surg; 1999 Sep; 5(5):381-7. PubMed ID: 10477839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation.
    Scouras NE; Matsusaki T; Boucek CD; Wells C; Cooper EA; Planinsic RM; Sullivan EA; Bermudez CA; Toyoda Y; Sakai T
    Liver Transpl; 2011 Feb; 17(2):137-43. PubMed ID: 21280186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation.
    Kett DH; Acosta RC; Campos MA; Rodriguez MJ; Quartin AA; Schein RM
    Liver Transpl; 2001 Jul; 7(7):645-8. PubMed ID: 11460234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristic haemodynamic changes of cirrhosis may influence the diagnosis of portopulmonary hypertension.
    Chiva T; Ripoll C; Sarnago F; Rincón D; Gómez-Camarero J; Galindo E; Catalina MV; Elizaga J; Bañares R
    Liver Int; 2015 Feb; 35(2):353-61. PubMed ID: 24797536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.